Literature DB >> 29868315

Diabetes Insipidus following Endoscopic Transsphenoidal Surgery for Pituitary Adenoma.

Abdulrazag M Ajlan1,2, Sarah Bin Abdulqader3, Achal S Achrol1, Yousef Aljamaan4, Abdullah H Feroze1, Laurence Katznelson1,5, Griffith R Harsh1.   

Abstract

Objectives  Pituitary adenoma (PA), among the most commonly encountered sellar pathologies, accounts for 10% of primary intracranial tumors. The reported incidence of postoperative diabetes insipidus (DI) is highly variable. In this study, we report our experience with DI following endoscopic transsphenoidal surgery (TSS) for PAs, elucidating the risk factors of postoperative DI, the likelihood of long-term DI, and the impact of DI on the length of stay (LOS). Methods  The study included 178 patients who underwent endoscopic resection of PAs. Early DI was defined as that occurring within the first postoperative week. The mean follow-up was 36 months. Long-term DI was considered as DI apparent in the last follow-up visit. Results  Of the 178 patients included in the study, 77% of the tumors were macroadenomas. Forty-seven patients (26%) developed early DI. Long-term DI was observed in 18 (10.1%) of the full cohort. Age younger than 50 years was significantly associated with a higher incidence of long-term DI ( p  = 0.02). Macroadenoma and gross total resection were significantly associated with higher incidence of early DI ( p  = 0.05 and p  = 0.04, respectively). The mean LOS was 4 days for patients with early postoperative DI and 3 days for those without it. Conclusion  The reported incidence of postoperative DI is significantly variable. We identified age younger than 50 years a risk factor for developing long-term postoperative DI. Gross total surgical resection and tumor size (> 1 cm) were associated with development of early DI. Early DI increased the LOS on average by 1 day.

Entities:  

Keywords:  diabetes insipidus; endoscopic transsphenoidal; pituitary adenoma; postoperative hypernatremia

Year:  2017        PMID: 29868315      PMCID: PMC5978855          DOI: 10.1055/s-0037-1604363

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  27 in total

Review 1.  Meta-analysis of endoscopic versus sublabial pituitary surgery.

Authors:  Timothy R DeKlotz; Stanley H Chia; Wenxin Lu; Kepher H Makambi; Edward Aulisi; Ziad Deeb
Journal:  Laryngoscope       Date:  2012-01-17       Impact factor: 3.325

2.  Giant pituitary adenomas: surgical outcomes of 50 cases operated on by the endonasal endoscopic approach.

Authors:  Jackson A Gondim; João Paulo C Almeida; Lucas Alverne F Albuquerque; Erika F Gomes; Michele Schops
Journal:  World Neurosurg       Date:  2013-08-29       Impact factor: 2.104

3.  Endoscopic endonasal approach for pituitary adenoma: surgical complications in 301 patients.

Authors:  Jackson A Gondim; Joao Paulo C Almeida; Lucas Alverne F Albuquerque; Michele Schops; Erika Gomes; Tania Ferraz; Wladia Sobreira; Meissa T Kretzmann
Journal:  Pituitary       Date:  2011-06       Impact factor: 4.107

Review 4.  Endoscopic versus microscopic trans-sphenoidal pituitary surgery: a systematic review and meta-analysis.

Authors:  J K Goudakos; K D Markou; C Georgalas
Journal:  Clin Otolaryngol       Date:  2011-06       Impact factor: 2.597

5.  DDAVP use in patients undergoing transsphenoidal surgery for pituitary adenomas.

Authors:  J M Sheehan; J P Sheehan; G L Douds; R B Page
Journal:  Acta Neurochir (Wien)       Date:  2005-12-20       Impact factor: 2.216

6.  Endoscopy assisted transsphenoidal surgery for pituitary adenoma. Technical note.

Authors:  H D Jho; R L Carrau
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

7.  Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas.

Authors:  Peter G Campbell; Erin Kenning; David W Andrews; Sanjay Yadla; Marc Rosen; James J Evans
Journal:  Neurosurg Focus       Date:  2010-10       Impact factor: 4.047

8.  Predictors of diabetes insipidus after transsphenoidal surgery: a review of 881 patients.

Authors:  Edward C Nemergut; Zhiyi Zuo; John A Jane; Edward R Laws
Journal:  J Neurosurg       Date:  2005-09       Impact factor: 5.115

9.  National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002.

Authors:  Chirag G Patil; Shivanand P Lad; Griffith R Harsh; Edward R Laws; Maxwell Boakye
Journal:  Neurosurg Focus       Date:  2007       Impact factor: 4.047

10.  Delayed Hyponatremia Is the Most Common Cause of 30-Day Unplanned Readmission After Transsphenoidal Surgery for Pituitary Tumors.

Authors:  Michael A Bohl; Shah Ahmad; Heidi Jahnke; Deborah Shepherd; Laura Knecht; William L White; Andrew S Little
Journal:  Neurosurgery       Date:  2016-01       Impact factor: 4.654

View more
  8 in total

1.  Impact of surgical factors on delayed hyponatremia in patients with nonfunctioning pituitary adenoma after endonasal endoscopic transsphenoidal procedure.

Authors:  Haku Tanaka; Fumihiko Nishimura; Kenta Nakase; Miho Kakutani; Shohei Yokoyama; Takayuki Morimoto; Taekyun Kim; Young-Soo Park; Ichiro Nakagawa; Shuichi Yamada; Kentaro Tamura; Ryosuke Matsuda; Yasuhiro Takeshima; Masashi Kotsugi; Hiroyuki Nakase
Journal:  Endocrine       Date:  2022-08-19       Impact factor: 3.925

2.  Change in cephalocaudal tumor cavity diameter after transsphenoidal surgery is a predictor of diabetes insipidus in pituitary adenoma.

Authors:  Kunzhe Lin; Kaichun Fan; Shuwen Mu; Shousen Wang
Journal:  Eur J Med Res       Date:  2022-05-25       Impact factor: 4.981

3.  Early hormonal recovery following endoscopic transsphenoidal surgery for silent non-functioning pituitary adenomas with hormone dysfunction.

Authors:  Min Ho Lee; Kyu Yeon Hur; Sang Duk Hong; Ho Jun Seol; Jung Won Choi; Jung- Il Lee; Do-Hyun Nam; Doo-Sik Kong
Journal:  J Neurooncol       Date:  2021-05-17       Impact factor: 4.130

4.  Postoperative water and electrolyte disturbances after extended endoscopic endonasal transsphenoidal surgery.

Authors:  Juan Manuel Canelo Moreno; Elena Dios Fuentes; Eva Venegas Moreno; Pablo Jesús Remón Ruíz; Cristina Muñoz Gómez; Ana Piñar Gutiérrez; Eugenio Cárdenas Valdepeñas; Ariel Kaen; Alfonso Soto Moreno
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-23       Impact factor: 6.055

5.  Is it possible to predict the development of diabetes insipidus after pituitary surgery? Study of 241 endoscopic transsphenoidal pituitary surgeries.

Authors:  M Araujo-Castro; F Mariño-Sánchez; A Acitores Cancela; A García Fernández; S García Duque; V Rodríguez Berrocal
Journal:  J Endocrinol Invest       Date:  2020-10-11       Impact factor: 4.256

6.  Predictive factors of postoperative diabetes insipidus in 333 patients undergoing transsphenoidal surgery for non-functioning pituitary adenoma.

Authors:  Yasuyuki Kinoshita; Akira Taguchi; Atsushi Tominaga; Tetsuhiko Sakoguchi; Kazunori Arita; Fumiyuki Yamasaki
Journal:  Pituitary       Date:  2021-07-20       Impact factor: 4.107

7.  Intraoperative central diabetes insipidus in a postpartum patient during decompression of base of brain lesion: Missing out the diagnosis of Sheehan's syndrome?

Authors:  Parmod K Bithal; Ravees Jan; Yasser Majid Butt; Khalid Alshuaibi
Journal:  Saudi J Anaesth       Date:  2021-04-01

Review 8.  Postoperative diabetes insipidus: how to define and grade this complication?

Authors:  Friso de Vries; Daniel J Lobatto; Marco J T Verstegen; Wouter R van Furth; Alberto M Pereira; Nienke R Biermasz
Journal:  Pituitary       Date:  2020-09-29       Impact factor: 4.107

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.